HomeACAD • NASDAQ
ACADIA Pharmaceuticals Inc
add
$21.98
2.00%
After Hours:(0.00%)0.00
$21.98
Closed: May 23, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 244.32M | 18.70% |
Operating expense | 126.37M | 17.02% |
Net income | 18.99M | 14.69% |
Net profit margin | 7.77 | -3.36% |
Earnings per share | 0.11 | 10.00% |
EBITDA | 22.24M | 7.25% |
Effective tax rate | 31.65% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 681.58M | 44.86% |
Total assets | 1.13B | 32.42% |
Total liabilities | 367.13M | -6.12% |
Total equity | 765.24M | — |
Shares outstanding | 167.36M | — |
Price to book | 4.71 | — |
Return on assets | 4.16% | — |
Return on capital | 6.01% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 18.99M | 14.69% |
Cash from operations | 20.32M | -30.11% |
Cash from investing | -124.05M | -783.60% |
Cash from financing | 1.84M | 76.22% |
Net change in cash | -101.89M | -733.35% |
Free cash flow | -173.24M | -323.36% |
Previous close
$21.55
Day range
$21.24 - $22.03
Year range
$13.40 - $25.23
Market cap
3.68B USD
Avg Volume
2.47M
P/E ratio
16.02
Dividend yield
-
Primary exchange
NASDAQ
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
654
